Treatment strategies for patients with peripheral artery disease
Jones WS, Schmit KM, Vemulapalli S, Subherwal S, Patel MR, Hasselblad V, Heidenfelder BL, Chobot MM, Posey R, Wing L, Sanders GD, Dolor RJ
Record ID 32013000727
English
Authors' objectives:
For patients with peripheral artery disease (PAD), the optimal treatment for cardiovascular protection, symptom relief, preservation of walking and functional status, and prevention of amputation is not known. This review assessed the comparative effectiveness of antiplatelet therapy, medical therapy, exercise, and endovascular and surgical revascularization in PAD patients with intermittent claudication (IC) or critical limb ischemia (CLI).
Authors' recommendations:
From a limited number of studies, it appears that aspirin has no benefit over placebo in the asymptomatic PAD patient; clopidogrel monotherapy is more beneficial than aspirin in the IC patient; and DAPT is not significantly better than aspirin at reducing cardiovascular events in patients with IC or CLI. For IC patients, exercise therapy, cilostazol, and endovascular intervention all had an effect on improving functional status and quality of life; the impact of these therapies on cardiovascular events and mortality is uncertain. The
comparisons of endovascular and surgical revascularization in CLI are primarily from observational studies, and the heterogeneity of the results makes conclusions for all clinical outcomes less certain. Several advances in care in both medical therapy and invasive therapy have not been rigorously tested and thus provide an impetus for further research.
Details
Project Status:
Completed
Year Published:
2013
URL for published report:
http://www.effectivehealthcare.ahrq.gov/ehc/products/368/1517/peripheral-artery-disease-treatment-report-130525.pdf
URL for additional information:
http://www.effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports/?pageaction=displayproduct&productid=1518
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Humans
- Peripheral Arterial Disease
Contact
Organisation Name:
Agency for Healthcare Research and Quality
Contact Address:
Center for Outcomes and Evidence Technology Assessment Program, 540 Gaither Road, Rockville, MD 20850, USA. Tel: +1 301 427 1610; Fax: +1 301 427 1639;
Contact Name:
martin.erlichman@ahrq.hhs.gov
Contact Email:
martin.erlichman@ahrq.hhs.gov
Copyright:
Agency for Healthcare Research and Quality (AHRQ)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.